Hjem › Aterosklerose › Idaho
Aterosklerose kliniske forsøg i Idaho
5 studier for Aterosklerose søger deltagere på steder i Idaho.
Byer i Idaho
Officiel studietekst (engelsk)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Elite Clinical Trials, Blackfoot
- High Desert Heart & Vascular, Meridian
- Elite Clinical Trials, Rexburg
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Boise, Meridian
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- St. Luke's Clinic - Idaho Cardiology Associates, Meridian
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07521007A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- High Desert Heart & Vascular, Meridian
RekruttererFase 3
Alder 45 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07613294A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Meridian
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.